http://www.unboundmedicine.com/medline/ebm/research/oxaliplatinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890960/full_citation/An_animal_model_for_chemotherapy_associated_steatohepatitis_and_its_prevention_by_the_oral_administration_of_fatty_acid_bile_acid_conjugate_Keizman D, Maimon N, Ish-Shalom M, et al. 
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate. [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890692/full_citation/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_Nishiyama M, Wada S 
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888874/full_citation/Satraplatin:_leading_the_new_generation_of_oral_platinum_agents_Bhargava A, Vaishampayan UN 
Satraplatin: leading the new generation of oral platinum agents. [Journal Article]
Expert Opin Investig Drugs 2009 Nov; 18(11):1787-97.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887868/full_citation/Economic_impact_of_alternative_adjuvant_chemotherapy_regimens_for_stage_III_colon_cancer_Goerner M, Riemer-Hommel P 
Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer. [Journal Article]
Onkologie 2009 Nov; 32(11):647-52.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887466/full_citation/Incidence_and_evolution_of_oxaliplatin_induced_peripheral_sensory_neuropathy_in_diabetic_patients_with_colorectal_cancer:_a_pooled_analysis_of_three_phase_III_studies_Ramanathan RK, Rothenberg ML, de Gramont A, et al. 
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886748/full_citation/Anti_cancer_activity_of_nitrones_in_the_Apc_Min/+__model_of_colorectal_cancer_Floyd RA, Towner RA, Wu D, et al. 
Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer. [JOURNAL ARTICLE]
Free Radic Res 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884549/full_citation/KRAS_and_BRAF_Mutations_in_Advanced_Colorectal_Cancer_Are_Associated_With_Poor_Prognosis_but_Do_Not_Preclude_Benefit_From_Oxaliplatin_or_Irinotecan:_Results_From_the_MRC_FOCUS_Trial_Richman SD, Seymour MT, Chambers P, et al. 
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881547/full_citation/Immunogenic_death_of_colon_cancer_cells_treated_with_oxaliplatin_Tesniere A, Schlemmer F, Boige V, et al. 
Immunogenic death of colon cancer cells treated with oxaliplatin. [JOURNAL ARTICLE]
Oncogene 2009 Nov 2.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19880627/full_citation/Hepatic_Toxicities_Associated_with_the_Use_of_Preoperative_Systemic_Therapy_in_Patients_with_Metastatic_Colorectal_Adenocarcinoma_to_the_Liver_Cleary JM, Tanabe KT, Lauwers GY, et al. 
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver. [JOURNAL ARTICLE]
Oncologist 2009 Oct 30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19875759/full_citation/Phase_II_study_of_oxaliplatin_plus_S_1_as_first_line_treatment_for_advanced_gastric_cancer__G_SOX_study__Koizumi W, Takiuchi H, Yamada Y, et al. 
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study). [JOURNAL ARTICLE]
Ann Oncol 2009 Oct 29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles